Free shipping on all orders over $ 500

T0901317

Cat. No. M2204
T0901317 Structure
Size Price Availability Quantity
10mg USD 85 In stock
50mg USD 220 In stock
Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

T0901317 is a potent, high affinity liver X receptor (LXR) agonist. T0901317 binds and activates PXR with the same nanomolar potency with which it stimulates LXR activity. T0901317 induces expression not only of LXR target genes, but also of PXR target genes in cells and animals. T0901317 decreases amyloid-β production in primary neurons in vitro. T0901317 also exhibits inverse agonist activity at constitutive androstane receptors (CAR). Although T0901317 is a much more potent activator of LXR than FXR, this ligand actually activates FXR more potently than a natural bile acid FXR ligand, chenodeoxycholic acid. T0901317 treatment of 11-week-old APP23 mice for 6 days showed a significant increase in ABCA1 expression and a decrease in the ratio of soluble APP (sAPP)beta- to sAPPalpha-cleavage products. T0901317 decreases amyloidogenic processing of APP in vitro and in vivo, thus supporting the search for potent and specific LXR ligands with properties allowing therapeutic application.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 481.33
Formula C17H12F9NO3S
CAS Number 293754-55-9
Purity >99%
Solubility DMSO 90 mg/mL
Ethanol 90 mg/mL
Storage at -20°C
References

The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.
Kumar N, et al. Mol Pharmacol. 2010 Feb;77(2):228-36. PMID: 19887649.

The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.
Koldamova RP, et al. J Biol Chem. 2005 Feb 11;280(6):4079-88. PMID: 15557325.

T0901317 is a dual LXR/FXR agonist.
Houck KA, et al. Mol Genet Metab. 2004 Sep-Oct;83(1-2):184-7. PMID: 15464433.

Related Liver X Receptor Products
SR9243

SR9243 is a potent and selective LXR inverse agonist.

GW3965 hydrochloride

GW3965 hydrochloride is a selective, orally active non-steroidal synthetic liver X receptor (LXR) agonist.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: T0901317 supplier, Liver X Receptor, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.